Risk factors and recurrent thrombotic episodes in patients with cerebral venous thrombosis

Blood Transfusion

Volumn 12, Issue SUPPL.1, 2014, Pages

  Tufano, Antonella ^a   Guida, Anna ^a   Coppola, Antonio ^a   Nardo, Assunta ^a   Capua, Mirko Di ^a   Quintavalle, Gabriele ^a   Di Minno, Matteo Nicola Dario ^a   Cerbone, Anna Maria ^a   Di Minno, Giovanni ^a  

^a FEDERICO II UNIVERSITY HOSPITAL   (Italy)

Author keywords

Cerebral venous thrombosis; Recurrences; Risk factors

Indexed keywords

ACTIVATED PROTEIN C RESISTANCE; ADULT; ANTIBODIES, ANTICARDIOLIPIN; ANTITHROMBIN III DEFICIENCY; AUTOIMMUNE DISEASES; CARDIOVASCULAR DISEASES; CASE-CONTROL STUDIES; CEREBRAL VEINS; COMORBIDITY; CONTRACEPTIVES, ORAL, HORMONAL; FACTOR V; FEMALE; HUMANS; HYPERHOMOCYSTEINEMIA; MALE; MIDDLE AGED; NEOPLASMS; OBESITY; PROMOTER REGIONS, GENETIC; PROTEIN C DEFICIENCY; PROTEIN S DEFICIENCY; PROTHROMBIN; RECURRENCE; RISK FACTORS; SMOKING; THROMBOPHILIA; VENOUS THROMBOSIS; YOUNG ADULT;

EID: 84893922669     PISSN: 17232007     EISSN: None     Source Type: Journal    
DOI: 10.2450/2013.0196-12     Document Type: Review

References (27)

1. Saadatnia M, Fatehi F, Basiri K, et al. Cerebral venous sinus thrombosis risk factors. Int J Stroke 2009; 4: 111-23.
2. Coutinho JM, Ferro JM, Canhao P, et al. Cerebral venous and sinus thrombosis in women. Stroke 2009; 40: 2356-61.
3. Stam J. Thrombosis of the cerebral vein and sinuses. N Engl J Med 2005; 352: 1791-8.
4. de Veber G, Andrew M, Adam C for the Canadian Pediatric Ischemic Stroke Study Group. Cerebral sinovenous thrombosis in children. N Engl J Med 2001; 345: 417-23.
5. Ferro JM, Canhao P, Stam J, et al. Prognosis of cerebral vein and dural sinus thrombosis: results of the International Study on Cerebral Vein and dural Sinus Thrombosis (ISCVT). Stroke 2004; 35: 664-70.
6. Canhao P, Ferro JM, Lindgren AG, et al. Causes and predictors of death in cerebral venous thrombosis. Stroke 2005, 36: 1720-5.
7. Dentali F, Poli D, Scoditti U, et al. Long-term outcomes of patients with cerebral vein thrombosis: a multicenter study. J Thromb Haemost 2012; 10: 1297-302.
8. Martinelli I, Sacchi E, Landi G, et al. High risk of cerebral vein thrombosis in carriers of a prothrombin-gene mutation and in users of oral contraceptives. N Engl J Med 1998; 338: 1793-7.
9. Madonna P, De Stefano V, Coppola A, et al. G20210A PRTH gene mutation and other thrombophilic polymorphisms in patients with cerebral vein thrombosis. Stroke 2000; 31: 1787-8.
10. Tufano A, Coppola A, Varricchione N, et al. Predisposing factors in patients with early-onset cerebral vein thrombosis. Thromb Res 2005; 115: 439-40.
11. Martinelli I, Battaglioli T, Pedotti P, et al. Hyperhomocysteinemia in cerebral vein thrombosis. Blood. 2003; 102: 1363-6.
12. Wattanakit K, Lutsey PL, Bell EJ, et al. Association between cardiovascular disease risk factors and occurrence of venous thromboembolism. A time-dependent analysis. Thromb Haemost 2012; 108: 508-15.
13. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acid Res 1988; 16: 1215.
14. Bertina RM, Koeleman BPC, Koster T, et al. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994; 369: 64-7.
15. Poort SR, Rosendaal FR, Reitsma PH, et al. A common genetic variation in the 3'-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 1996; 88: 3698-703.
16. Brandt JT, Triplett DA, Alving B, et al. Criteria for the diagnosis of lupus anticoagulants: an update. Thromb Haemost 1995; 74: 1185-90.
17. Di Capua M, Coppola A, Albisinni R, et al. Cardiovascular risk factors and outcome in patients with retinal vein occlusion. J Thromb Thrombolysis 2010; 30: 16-22.
18. Tufano A, Macarone Palmieri N, Cimino E, et al. Budd-Chiari syndrome in a paroxysmal nocturnal hemoglobinuria patient with previous cerebral venous thrombosis. Intern Emerg Med 2009; 4: 75-7.
19. Ludemann P, Nabavi DG, Junker R, et al. Factor V Leiden mutation is a risk factor for cerebral vein thrombosis: a casecontrol study of 55 patients. Stroke 1998; 29: 2507-10.
20. Martinelli I. Unusual forms of venous thrombosis and thrombophilia. Pathophysiol Haemost Thromb 2002; 32: 343-5.
21. De Stefano V, Rossi E, Za T, et al. JAK-2V61F mutational frequency in essential thrombocythemia associated with splanchnic or cerebral vein thrombosis. Am J Hematol 2011; 86: 526-8.
22. Kahn SR, Lim W, Dunn AS, et al. Prevention of VTE in nonsurgical patients: antithrombotic therapy and prevention of thrombosis. 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012; 141; e195S-e226S.
23. Miranda B, Ferro JM, Canhao P, et al. Venous thromboembolic events after cerebral vein thrombosis. Stroke 2012; 41: 1901-6.
24. Gosk-Bierska I, Wysokinski W, Brown RD, et al. Cerebral venous sinus thrombosis: incidence of venous thrombosis recurrence and survival. Neurology 2006; 67: 814-9.
25. Martinelli I, Bucciarelli P, Passamonti SM, et al. Long term evaluation of the risk of recurrence after cerebral sinus venous thrombosis. Circulation 2010; 121: 2740-6.
26. Middeldorp S. Is thrombophilic testing useful? Hematology Am Soc Hematol Educ Program 2011; 2011: 150-5.
27. Coppola A, Tufano A, Cerbone AM, Di Minno G. Inherited thrombophilia: implications for prevention and treatment of venous thromboembolism. Semin Thromb Hemost 2009; 35: 683-94.